ATE309264T1 - Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren - Google Patents

Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren

Info

Publication number
ATE309264T1
ATE309264T1 AT98915572T AT98915572T ATE309264T1 AT E309264 T1 ATE309264 T1 AT E309264T1 AT 98915572 T AT98915572 T AT 98915572T AT 98915572 T AT98915572 T AT 98915572T AT E309264 T1 ATE309264 T1 AT E309264T1
Authority
AT
Austria
Prior art keywords
amino
peptidyl
protease inhibitors
acids
cysteine protease
Prior art date
Application number
AT98915572T
Other languages
English (en)
Inventor
Ron Bihovsky
Ming Tao
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Application granted granted Critical
Publication of ATE309264T1 publication Critical patent/ATE309264T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98915572T 1997-04-18 1998-04-15 Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren ATE309264T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4467697P 1997-04-18 1997-04-18
PCT/US1998/007499 WO1998047523A1 (en) 1997-04-18 1998-04-15 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
US09/060,491 US6348448B1 (en) 1997-04-18 1998-04-15 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors

Publications (1)

Publication Number Publication Date
ATE309264T1 true ATE309264T1 (de) 2005-11-15

Family

ID=26721855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98915572T ATE309264T1 (de) 1997-04-18 1998-04-15 Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren

Country Status (10)

Country Link
US (2) US6348448B1 (de)
EP (1) EP0975353B1 (de)
JP (1) JP4144811B2 (de)
AT (1) ATE309264T1 (de)
AU (1) AU733420B2 (de)
CA (1) CA2286722C (de)
DE (1) DE69832268T2 (de)
ES (1) ES2252831T3 (de)
NZ (1) NZ500045A (de)
WO (1) WO1998047523A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645939B1 (en) 1997-11-24 2003-11-11 Merck & Co., Inc. Substituted β-alanine derivatives as cell adhesion inhibitors
EP1034164B1 (de) * 1997-11-24 2004-05-19 Merck & Co., Inc. Beta-alanin-derivate als zell-adhäsions-inhibitoren
WO2003024923A1 (en) * 2001-09-14 2003-03-27 Axys Pharmaceuticals, Inc. Sulfonamide compounds as protease inhibitors
EP2720692A4 (de) * 2011-06-17 2015-05-20 Virobay Inc Cathepsinhemmer zur behandlung microglia-vermittelten neuronenverlusts im zentralnervensystem
JP6306504B2 (ja) 2011-07-01 2018-04-04 ノボザイムス アクティーゼルスカブ 液体洗剤組成物
MX346246B (es) 2011-07-01 2017-03-13 Novozymes As Composicion de subtilisina estabilizada.
WO2014152674A1 (en) 2013-03-14 2014-09-25 Novozymes A/S Enzyme and inhibitor containing water-soluble films
JP7020778B2 (ja) 2013-05-03 2022-02-16 ノボザイムス アクティーゼルスカブ 洗剤酵素のマイクロカプセル化
US20170121646A1 (en) 2014-07-03 2017-05-04 Novozymes A/S Improved Stabilization of Non-Protease Enzyme
EP3741848A3 (de) 2014-12-19 2021-02-17 Novozymes A/S Proteasevarianten und dafür codierende polynukleotide
EP3950939A3 (de) 2015-07-06 2022-06-08 Novozymes A/S Lipasevarianten und polynukleotide zur codierung davon
CN120005686A (zh) 2017-05-05 2025-05-16 诺维信公司 包含脂肪酶和亚硫酸根的组合物
CN111108183A (zh) 2017-06-30 2020-05-05 诺维信公司 酶浆液组合物
EP3704219B1 (de) 2017-11-01 2024-01-10 Novozymes A/S Polypeptide und zusammensetzungen mit solchen polypeptiden
CN111479919A (zh) 2017-11-01 2020-07-31 诺维信公司 多肽以及包含此类多肽的组合物
WO2019175240A1 (en) 2018-03-13 2019-09-19 Novozymes A/S Microencapsulation using amino sugar oligomers
EP3647398B1 (de) 2018-10-31 2024-05-15 Henkel AG & Co. KGaA Reinigungszusammensetzungen mit dispersinen v
EP3647397A1 (de) 2018-10-31 2020-05-06 Henkel AG & Co. KGaA Reinigungsmittel mit dispersins iv
MX2021015894A (es) 2019-07-01 2022-02-03 Basf Se Peptidos acetales para estabilizar enzimas.
US20220411773A1 (en) 2019-12-20 2022-12-29 Novozymes A/S Polypeptides having proteolytic activity and use thereof
WO2022189521A1 (en) 2021-03-12 2022-09-15 Novozymes A/S Polypeptide variants
EP4638687A2 (de) 2022-12-23 2025-10-29 Novozymes A/S Katalase und amylase enthaltendes waschmittel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3481913D1 (de) 1983-04-27 1990-05-17 Ici America Inc Prolin-derivate.
JPH075634B2 (ja) * 1987-10-30 1995-01-25 日東紡績株式会社 トリペプチド類及びこれを含有する抗プラスミン剤
DE4101895C1 (de) 1991-01-23 1991-12-05 Forschungszentrum Juelich Gmbh, 5170 Juelich, De
US5436229A (en) 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
ATE192432T1 (de) 1995-11-16 2000-05-15 Searle & Co N-geschützte/n-substituierte beta- aminohydroxysulfonate

Also Published As

Publication number Publication date
NZ500045A (en) 2001-02-23
CA2286722A1 (en) 1998-10-29
CA2286722C (en) 2010-10-19
EP0975353A4 (de) 2001-11-28
DE69832268T2 (de) 2006-07-13
US6348448B1 (en) 2002-02-19
HK1025511A1 (en) 2000-11-17
DE69832268D1 (en) 2005-12-15
US6500802B1 (en) 2002-12-31
AU6972098A (en) 1998-11-13
JP2001520674A (ja) 2001-10-30
WO1998047523A1 (en) 1998-10-29
EP0975353B1 (de) 2005-11-09
ES2252831T3 (es) 2006-05-16
EP0975353A1 (de) 2000-02-02
JP4144811B2 (ja) 2008-09-03
AU733420B2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
ATE309264T1 (de) Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
ATE377006T1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
DK0871454T3 (da) Phosphorholdige inhibitorer af cystein- og serinprotease
ATE335485T1 (de) Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease
EP0677048A1 (de) Cyclische sulfone als inhibitoren retroviralen proteasen.
ATE233552T1 (de) Thiol-sulfonen als metalloproteinaseinhibitoren
NO990855L (no) Substituerte sykliske amin-metallprotease-inhibitorer
DE69530993D1 (de) Multikatalytische protease-inhibitoren
NO991832D0 (no) Inhibitorer for serin-proteaser, spesielt hepatitt - C - virus NS3-protease
MY113489A (en) Reversible protease inhibitors
NO990548D0 (no) Inhibitorer for cystein-protease
ATE326454T1 (de) Neue bernsteinsäure derivative als cysteine- protease-inhibitoren
TR200003028T2 (tr) Yeni ikame edilmiş amidler, bunların üretimi ve kullanımı.
BG104885A (en) Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
DE69326077D1 (de) Sulfonylalkanoylaminohydroxyethylaminosulfaminsäuren verwendbar als inhibitoren retroviraler proteasen
EA199800200A1 (ru) Ингибиторы пролилэндопептидазы
CA2342985A1 (en) Hydroxamate-containing cysteine and serine protease inhibitors
DE59900730D1 (de) Korrosionsinhibitoren enthaltender Injektionszement
ATE330961T1 (de) Phosphonsäureverbindungen als inhibitoren von serinproteasen
DE59812724D1 (de) Serin-proteinase-inhibitoren
DE60015559D1 (de) Sentrin-spezifische menschliche protease senp1
ATE197716T1 (de) Waschmittelenzyme
DE59905355D1 (de) Verwendung von katecholderivaten als proteinaseinhibitoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975353

Country of ref document: EP